ESS
65
5
ILMN
46
-4
KMX
58
-2
O
35
4
MOS
46
-3
PRU
54
-2
REGN
42
3
PHM
63
4
CA
22
12
PEG
60
5
EQIX
65
3
PSA
60
5
AIG
42
-2
PVH
65
-3
BBY
43
-2
SE
50
-5
MTCH
26
-7
XYL
41
4
SYK
64
2
BEN
34
-3
ESS
65
5
ILMN
46
-4
KMX
58
-2
O
35
4
MOS
46
-3
PRU
54
-2
REGN
42
3
PHM
63
4
CA
22
12
PEG
60
5
EQIX
65
3
PSA
60
5
AIG
42
-2
PVH
65
-3
BBY
43
-2
SE
50
-5
MTCH
26
-7
XYL
41
4
SYK
64
2
BEN
34
-3
Financhill
Back

Enterprise Financial Services Vs. Rhythm Pharmaceuticals Industry Stock Comparison

Buy
61

EFSC
Enterprise Financial Services

Last Price:
58.26
Seasonality Move:
3.17%
Buy
100

RYTM
Rhythm Pharmaceuticals

Last Price:
67.31
Seasonality Move:
9.98%
Buy
61
Enterprise Financial Services (EFSC) is a Buy

Is Enterprise Financial Services a Buy, Sell or Hold?

  • The current Enterprise Financial Services [EFSC] share price is $58.28. The Score for EFSC is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • EFSC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
100
Rhythm Pharmaceuticals (RYTM) is a Buy

Is Rhythm Pharmaceuticals a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals [RYTM] share price is $67.33. The Score for RYTM is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
  • RYTM is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

EFSC Stock Price Chart

What is Enterprise Financial Services's stock price today?

  • The Enterprise Financial Services share price today is $58.28
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EFSC is experiencing buying pressure, which is a positive indicator for future bullish movement.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals's stock price today?

  • The Rhythm Pharmaceuticals share price today is $67.33
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.

EFSC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.65 Buy
Relative Strength Index (14 RSI): 64.06 Buy
Chaikin Money Flow: 101348 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 55.54) Buy
Bollinger Bands (100): (44.28 - 54.14) Buy

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.14 Buy
Relative Strength Index (14 RSI): 81.29 Buy
Chaikin Money Flow: 966983 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.36 - 56.78) Buy
Bollinger Bands (100): (43.87 - 52.87) Buy

EFSC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 55.3 Buy
20-day SMA: 53.57 Buy
50-day SMA: 51.92 Buy
200-day SMA: 44.31 Buy
8-day EMA: 56.05 Buy
20-day EMA: 54.04 Buy
50-day EMA: 52.01 Buy
200-day EMA: 46.5 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.18 Buy
20-day SMA: 52.43 Buy
50-day SMA: 50.91 Buy
200-day SMA: 45.07 Buy
8-day EMA: 58.59 Buy
20-day EMA: 54.14 Buy
50-day EMA: 51.2 Buy
200-day EMA: 44.61 Buy

Enterprise Financial Services Earnings Growth & EFSC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.37 per share, and a decrease next year of $0.19 per share.

Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.21 per share, and an increase next year of $1.66 per share.

Enterprise Financial Services Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):